A detailed history of Allworth Financial LP transactions in Veracyte, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 33 shares of VCYT stock, worth $1,486. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33
Holding current value
$1,486
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$31.92 - $44.4 $1,053 - $1,465
33 New
33 $1,000
Q2 2024

Jul 23, 2024

BUY
$18.86 - $23.55 $2,432 - $3,037
129 Added 758.82%
146 $3,000
Q1 2024

Apr 25, 2024

SELL
$21.0 - $29.1 $1,575 - $2,182
-75 Reduced 81.52%
17 $0
Q4 2023

Jan 24, 2024

BUY
$19.72 - $28.68 $1,715 - $2,495
87 Added 1740.0%
92 $2,000
Q3 2023

Oct 31, 2023

BUY
$22.33 - $29.92 $111 - $149
5 New
5 $0

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3.23B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.